Product NDC: | 61958-0602 |
Proprietary Name: | Emtriva |
Non Proprietary Name: | EMTRICITABINE |
Active Ingredient(s): | 10 mg/mL & nbsp; EMTRICITABINE |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61958-0602 |
Labeler Name: | Gilead Sciences, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021896 |
Marketing Category: | NDA |
Start Marketing Date: | 20050928 |
Package NDC: | 61958-0602-1 |
Package Description: | 1 BOTTLE, DISPENSING in 1 CARTON (61958-0602-1) > 170 mL in 1 BOTTLE, DISPENSING |
NDC Code | 61958-0602-1 |
Proprietary Name | Emtriva |
Package Description | 1 BOTTLE, DISPENSING in 1 CARTON (61958-0602-1) > 170 mL in 1 BOTTLE, DISPENSING |
Product NDC | 61958-0602 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | EMTRICITABINE |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20050928 |
Marketing Category Name | NDA |
Labeler Name | Gilead Sciences, Inc. |
Substance Name | EMTRICITABINE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |